Back to search

National and Kapodistrian University of Athens

Σχεδιασμός, σύνθεση και φαρμακολογική αξιολόγηση νέων υποκατεστημένων πυραζολοπυριδινών ως αναστολέων πρωτεϊνικών κινασών

Abstract

dc:description

The present Thesis deals with the design, synthesis and pharmacological evaluation of some new substituted pyrazolopyridines. The prepared compounds are divided into two groups: The first includes derivatives of pyrazolo[3,4-c]pyridine and pyrazolo[4,3-b]pyridine, which bear 3-arylmethyl together with 5-amino or 7-hydroxy substitution while the second group includes derivatives of 3-phenyl or 3-benzylpyrazolo[3,4-c]pyridine which possess a 5-arylamino substitution and may also contain an additional substituent at position 1. The preparation of the compounds of the first group was made using the 3-acetamides of 2- or 4-picoline which are suitably substituted with methoxy- or Boc-substituted aminogroup. These acetamides were obtained through the chemical manipulation of commercially available picolines and were then lithiated, coupled to suitable benzylchlorides and ring-closed to result in the corresponding pyrazolopyridines. Finally, removal of the protecting groups provided the target heterocycles. The synthesis of the 3-phenyl substituted derivatives belonging to the second group was effected through initial preparation of 3-iodo-5-chloropyrazolo[3,4-c]pyridine, application of a Suzuki-type coupling to result in the corresponding 3-phenyl analog, which then reacted with suitably substituted anilines in the presence of palladium catalyst to give the target 5-arylamino substituted derivatives. Following an analogous procedure, the 3-benzyl substituted derivatives were prepared, starting from 3-benzylpyrazolo[3,4-c]pyridine. Analogs with the incorporation of 1-methyl or 1-(4-methoxy)benzyl group were also prepared. The pharmacological evaluation of the compounds belonging to the second group has already been performed. The inhibitory activity has been tested against CDK 1, CDK4, PLK1, PLK2, PLK3, PLK4, AUR-B and GSK3 and it has been shown that the 1-methylsubstituted derivatives which possess a 5-(4-carboxy)phenylamino group are the most potent inhibitors. The presence of a bulky substituent at position 1 is not favourable for the activity, while the presence of a 3-phenyl or 3-benzyl group results in compounds with similar inhibitory properties.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Λουγιάκης, Νικόλαος
  • Lougiakis, Nikolaos

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/25439

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Λουγιάκης, Νικόλαος; Lougiakis, Nikolaos. Σχεδιασμός, σύνθεση και φαρμακολογική αξιολόγηση νέων υποκατεστημένων πυραζολοπυριδινών ως αναστολέων πρωτεϊνικών κινασών. National and Kapodistrian University of Athens, 2008. http://hdl.handle.net/10442/hedi/25439